The introduction of the Shield™ test for colorectal cancer screening marks a transformative step in advancing precision and ...

London – M42, a global health leader powered by artificial intelligence (AI), and Hikma Pharmaceuticals PLC (Hikma), ...

(MENAFN- AETOSWire) Hikma Pharmaceuticals PLC (Hikma), the multinational ... Mazen Darwazah, Hikma's Executive Vice Chairman and President of MENA, said: “We are proud to sign this strategic ...

(MENAFN- Mid-East Info) M42, a global health leader powered by artificial intelligence (AI), and Hikma Pharmaceuticals PLC ... Vice Chairman and President of MENA, said:“We are proud to sign ...

Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, reported today ...

Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial ...

Dividend amount and dividend per share are quoted in the currency of the stock selected. Please note that past performance is not a reliable indicator of future returns. Important Information Please ...

Hikma Pharmaceuticals PLC develops, manufactures and markets a broad range of branded and non-branded generic pharmaceutical products across the US, the MENA region, and Europe.

Hikma Pharmaceuticals PLC hit a new 52-week high, surpassing its previous peak of £23.14, which the company achieved on ...